drugset / Trial / NCT00956306
A Pharmacokinetic Study of Udenafil in Adult Subjects With or Without Impaired Hepatic Function
Non-randomizedParallel-groupOpen-labelSupportive care
Summary
This study is designed to assess the effect of hepatic impairment on the pharmacokinetics, safety and tolerability of udenafil in subjects with hepatic impairment compared to healthy subjects.
Timeline
- Start
- 2007-11
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Udenafil | Small molecule | 100 mg | Oral |
Indications
No indication recorded.